tiprankstipranks
Trending News
More News >
INNOVATE Corp (VATE)
:VATE
US Market
Advertisement

INNOVATE Corp (VATE) Earnings Dates, Call Summary & Reports

Compare
265 Followers

Earnings Data

Report Date
Mar 11, 2026
After Close (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
Last Year’s EPS
-1.29
Same Quarter Last Year
Based on 0 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Nov 12, 2025|
% Change Since:
|
Earnings Call Sentiment|Neutral
The earnings call highlighted strong revenue growth and strategic advancements in various segments, such as significant backlog increases and regulatory approvals. However, there were challenges such as margin compression, declines in Spectrum revenue, and increased indebtedness.
Company Guidance
During the third quarter of 2025 earnings call, INNOVATE Corp reported consolidated revenues of $347.1 million, marking a 43.3% increase from the previous year, driven primarily by the Infrastructure segment. Adjusted EBITDA for the quarter was $19.8 million, up from $16.8 million in the prior year. The Infrastructure segment, with revenues of $338.4 million and adjusted EBITDA of $23.5 million, experienced gross margin compression of 510 basis points to 13.6% and adjusted EBITDA margin compression of 200 basis points year-over-year. DBM Global's backlog increased by $500 million, reaching $1.6 billion. In Life Sciences, MediBeacon received regulatory approval in China for its Lumitrace injection, while R2's revenues grew to $3.1 million with a 65% year-over-year increase. Spectrum's revenues decreased to $5.6 million, with adjusted EBITDA dropping to $1 million due to challenges in the advertising market. The company ended the quarter with $35.5 million in cash and $700.4 million in total principal outstanding indebtedness.
Strong Revenue Growth
Consolidated total revenue for the third quarter of 2025 was $347.1 million, an increase of 43.3% compared to $242.2 million in the prior year period.
DBM Global Backlog Increase
DBM Global's adjusted backlog increased by approximately $500 million to just over $1.6 billion since the end of 2024.
MediBeacon Regulatory Approval
MediBeacon received full regulatory approval from China's National Medical Products Administration for its Lumitrace injection, unlocking access to a critical healthcare market.
R2 Revenue and Sales Growth
R2's year-to-date revenues increased by 65% over the same period last year, with outside North America revenue surging 206% and system sales increasing by 392%.
Spectrum Content Portfolio Expansion
Spectrum strengthened its content portfolio with new network launches, including Lionsgate's MovieSphere Gold Channel and Sports First, reaching 45 U.S. markets.

INNOVATE Corp (VATE) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

VATE Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Mar 11, 2026
2025 (Q4)
- / -
-1.292
Nov 12, 2025
2025 (Q3)
- / -0.71
-1.1839.92% (+0.47)
Aug 05, 2025
2025 (Q2)
- / -1.67
0.977-271.24% (-2.65)
May 06, 2025
2025 (Q1)
- / -1.89
-2.24915.96% (+0.36)
Mar 31, 2025
2024 (Q4)
- / -1.89
-2.24915.92% (+0.36)
Nov 06, 2024
2024 (Q3)
- / -1.18
-0.924-27.71% (-0.26)
Aug 07, 2024
2024 (Q2)
- / 0.98
-1.338173.02% (+2.31)
May 07, 2024
2024 (Q1)
- / -2.25
-1.303-72.60% (-0.95)
Mar 04, 2024
2023 (Q4)
- / -1.21
-0.896-35.49% (-0.32)
Nov 09, 2023
2023 (Q3)
- / -0.92
-0.844-9.48% (-0.08)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

VATE Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 12, 2025
$5.47$5.60+2.38%
Aug 05, 2025
$5.76$5.68-1.39%
May 06, 2025
$6.24$6.15-1.44%
Mar 31, 2025
$7.83$7.31-6.64%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does INNOVATE Corp (VATE) report earnings?
INNOVATE Corp (VATE) is schdueled to report earning on Mar 11, 2026, After Close (Confirmed).
    What is INNOVATE Corp (VATE) earnings time?
    INNOVATE Corp (VATE) earnings time is at Mar 11, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is VATE EPS forecast?
          Currently, no data Available
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis